Most-read rankings are recalculated at the beginning of the month and are based on full-text and pdf views.

1.	A J Berry, M G Rinaldi, J R Graybill
		Use of high-dose fluconazole as salvage therapy for cryptococcal meningitis in patients with AIDS.
		Antimicrob. Agents Chemother. Mar 01, 1992; 36: 690-692. (In "Research Article")   [Abstract]     [PDF]
2.	Solène Grayo, Marie-Catherine Lott-Desroches, Olivier Dussurget, Renaud Respaud, Arnaud Fontanet, Olivier Join-Lambert, Eric Singlas, Alban Le Monnier
		Rapid eradication of Listeria monocytogenes by moxifloxacin in a murine model of central nervous system listeriosis
		Antimicrob. Agents Chemother. Jun 23, 2008; doi: 10.1128/AAC.00177-08. (In "Articles")   [Abstract]     [PDF]
3.	Spotswood L. Spruance, Julia E. Reid, Michael Grace, Matthew Samore
		Hazard Ratio in Clinical Trials
		Antimicrob. Agents Chemother. Aug 01, 2004; 48: 2787-2792. (In "Minireviews")   [Full Text]     [PDF]
4.	Tuberculosis Drug Screening Program
		Search for New Drugs for Treatment of Tuberculosis
		Antimicrob. Agents Chemother. Jul 01, 2001; 45: 1943-1946. (In "Guest Commentary")   [Full Text]     [PDF]
5.	Sarah Palmer, Robert W. Shafer, Thomas C. Merigan
		Hydroxyurea Enhances the Activities of Didanosine, 9-[2-(Phosphonylmethoxy)ethyl]adenine, and 9-[2-(Phosphonylmethoxy)propyl]adenine against Drug-Susceptible and Drug-Resistant Human Immunodeficiency Virus Isolates
		Antimicrob. Agents Chemother. Aug 01, 1999; 43: 2046-2050. (In "Antiviral Agents")   [Abstract]     [Full Text]     [PDF]
6.	Cody C. Cain, Dongho Lee, Robert H. Waldo III, Alexis T. Henry, Earl J. Casida, Mansukh C. Wani, Monroe E. Wall, Nicholas H. Oberlies, Joseph O. Falkinham III
		Synergistic Antimicrobial Activity of Metabolites Produced by a Nonobligate Bacterial Predator
		Antimicrob. Agents Chemother. Jul 01, 2003; 47: 2113-2117. (In "Susceptibility")   [Abstract]     [Full Text]     [PDF]
7.	Alexander Sulakvelidze, Zemphira Alavidze, J. Glenn Morris
		Bacteriophage Therapy
		Antimicrob. Agents Chemother. Mar 01, 2001; 45: 649-659. (In "Minireviews")   [Full Text]     [PDF]
8.	J. M. Rolain, P. Brouqui, J. E. Koehler, C. Maguina, M. J. Dolan, D. Raoult
		Recommendations for Treatment of Human Infections Caused by Bartonella Species
		Antimicrob. Agents Chemother. Jun 01, 2004; 48: 1921-1933. (In "Minireviews")   [Full Text]     [PDF]
9.	Stephen H. Gillespie
		Evolution of Drug Resistance in Mycobacterium tuberculosis: Clinical and Molecular Perspective
		Antimicrob. Agents Chemother. Feb 01, 2002; 46: 267-274. (In "Minireviews")   [Full Text]     [PDF]
10.	Robert E. W. Hancock, Daniel S. Chapple
		Peptide Antibiotics
		Antimicrob. Agents Chemother. Jun 01, 1999; 43: 1317-1323. (In "Minireviews")   [Full Text]     [PDF]
11.	DP Nicolau, CD Freeman, PP Belliveau, CH Nightingale, JW Ross, R Quintiliani
		Experience with a once-daily aminoglycoside program administered to 2,184 adult patients
		Antimicrob. Agents Chemother. Mar 01, 1995; 39: 650-655. (In "Articles")   [Abstract]     [PDF]
12.	David J. Weber, William A. Rutala, Emily E. Sickbert-Bennett
		Outbreaks Associated with Contaminated Antiseptics and Disinfectants
		Antimicrob. Agents Chemother. Dec 01, 2007; 51: 4217-4224. (In "Minireviews")   [Full Text]     [PDF]
13.	T. P. Lodise, J. Graves, A. Evans, E. Graffunder, M. Helmecke, B. M. Lomaestro, K. Stellrecht
		Relationship between Vancomycin MIC and Failure among Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia Treated with Vancomycin
		Antimicrob. Agents Chemother. Sep 01, 2008; 52: 3315-3320. (In "Clinical Therapeutics")   [Abstract]     [Full Text]     [PDF]
14.	Aurélie Thiolas, Claude Bollet, Bernard La Scola, Didier Raoult, Jean-Marie Pagès
		Successive Emergence of Enterobacter aerogenes Strains Resistant to Imipenem and Colistin in a Patient
		Antimicrob. Agents Chemother. Apr 01, 2005; 49: 1354-1358. (In "Mechanisms Of Resistance")   [Abstract]     [Full Text]     [PDF]
15.	Christian G. Giske, Dominique L. Monnet, Otto Cars, Yehuda Carmeli, on behalf of ReAct-Action on Antibiotic Resistance
		Clinical and Economic Impact of Common Multidrug-Resistant Gram-Negative Bacilli
		Antimicrob. Agents Chemother. Mar 01, 2008; 52: 813-821. (In "Minireviews")   [Full Text]     [PDF]
16.	Federico Perez, Andrea M. Hujer, Kristine M. Hujer, Brooke K. Decker, Philip N. Rather, Robert A. Bonomo
		Global Challenge of Multidrug-Resistant Acinetobacter baumannii
		Antimicrob. Agents Chemother. Oct 01, 2007; 51: 3471-3484. (In "Minireviews")   [Full Text]     [PDF]
17.	Thomas P. Lodise, Ben Lomaestro, Jeffrey Graves, G. L. Drusano
		Larger Vancomycin Doses (at Least Four Grams per Day) Are Associated with an Increased Incidence of Nephrotoxicity
		Antimicrob. Agents Chemother. Apr 01, 2008; 52: 1330-1336. (In "Clinical Therapeutics")   [Abstract]     [Full Text]     [PDF]
18.	Todd P. Levin, Byungse Suh, Peter Axelrod, Allan L. Truant, Thomas Fekete
		Potential Clindamycin Resistance in Clindamycin-Susceptible, Erythromycin-Resistant Staphylococcus aureus: Report of a Clinical Failure
		Antimicrob. Agents Chemother. Mar 01, 2005; 49: 1222-1224. (In "Mechanisms Of Resistance")   [Abstract]     [Full Text]     [PDF]
19.	Marie-Paule Mingeot-Leclercq, Paul M. Tulkens
		Aminoglycosides: Nephrotoxicity
		Antimicrob. Agents Chemother. May 01, 1999; 43: 1003-1012. (In "Minireviews")   [Full Text]     [PDF]
20.	J. L. Martinez, F. Baquero
		Mutation Frequencies and Antibiotic Resistance
		Antimicrob. Agents Chemother. Jul 01, 2000; 44: 1771-1777. (In "Minireviews")   [Full Text]     [PDF]

= from the current issue

Last Updated: 11/05/2008 20:34:47